Evaluating resting-state BOLD variability in relation to biomarkers of preclinical Alzheimer's disease. Millar PR, Ances BM, Gordon BA, Benzinger TLS, et al. Neurobiol Aging 2020;96:233-245.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Millar PR, Ances BM, Gordon BA, Benzinger TLS, et al. Evaluating resting-state BOLD variability in relation to biomarkers of preclinical Alzheimer's disease. Neurobiol Aging 2020;96:233-245.
PMID: 33039901